Navigation Links
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd.
Date:6/5/2008

s," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements including, limited operating history, need for future capital, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic reports.

These statements, and other forward-looking statements, are not guarantees of future performance and involve risks and uncertainties. Crystal Research Associates assumes no obligation to update any of the forward-looking statements in this release.


'/>"/>
SOURCE Crystal Research Associates, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NC State breakthrough results in super-hard nanocrystalline iron that can take the heat
2. CRELUX and ProQinase establish joint crystal-grade kinase protein and structures platform
3. DiObex and Camurus Sign License Agreement for the Development of DIO-901 in FluidCrystal(R) Extended Release Technology
4. DNA technique yields 3-D crystalline organization of nanoparticles
5. Researchers outline structure of largest nonvirus particle ever crystallized
6. 3-D photonic crystals will revolutionize telecommunications
7. Recombinant Human Renin - Crystallographic Grade
8. Interleukin Genetics to Present at the 13th International Conference on Periodontal Research
9. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
10. Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at ASGT Meeting
11. HistoRx Announces Expanded Access of AQUA(R) Technology to 900+ Researchers at Dana-Farber/Harvard Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email: